NEW YORK, Sept. 12, 2017 -- Japan Smaller Capitalization Fund, Inc. (NYSE:JOF) (the “Fund”) announced that it will hold its 2017 Annual Meeting of Shareholders (the “Meeting”) at the offices of Nomura Asset Management U.S.A. Inc., Worldwide Plaza, 309 West 49th Street, 28th Floor, New York, New York, on Wednesday, November 15, 2017, at 10:30 A.M. to consider the election of one Director to serve as a Class II Director, to serve for a term to expire in 2020. The record date for determining shareholders entitled to participate in the Meeting is September 21, 2017.
The Fund invests primarily in the securities of smaller capitalization companies in Japan and is designed for investors seeking long-term capital appreciation. The Manager of the Fund is Nomura Asset Management U.S.A. Inc., which is based in New York. Nomura Asset Management U.S.A. Inc. is a subsidiary of Nomura Asset Management Co., Ltd., which is one of the largest investment advisory companies in Japan in terms of assets under management and which serves as the Investment Adviser to the Fund.
Contact:
Maria R. Premole
Nomura Asset Management U.S.A. Inc.
Worldwide Plaza
309 West 49th Street
New York, NY 10019
(800) 833-0018


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 



